Unfractionated heparin or fondaparinux in elderly patients with non-ST-elevation acute coronary syndrome: different effect on fibrinolytic status at day 8

被引：0
|
作者：
Averkov, O. [1 ]
Skutnitskaya, L. [1 ]
Kobalava, Z. [1 ]
机构：
[1] Russian Peoples Friendship Univ, Dept Propedeut Internal Med, Moscow, Russia
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-TH-223
引用
收藏
页码：1009 / 1009
页数：1
相关论文
共 50 条
  • [41] Cost-effectiveness of fondaparinux versus enoxaparin in non-ST-elevation acute coronary syndrome in Canada (OASIS-5)
    Terres, Jorge Alfonso Ross
    Lozano-Ortega, G.
    Kendall, R.
    Sculpher, M. J.
    BMC CARDIOVASCULAR DISORDERS, 2015, 15
  • [42] Effect of hyponatremia (< 135 mEq/L) on outcome in patients with Non-ST-elevation acute coronary syndrome
    Singla, Ish
    Zahid, Maliha
    Good, Chester B.
    Macioce, Alanna
    Sonel, Ali F.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (03): : 406 - 408
  • [43] Invasive strategy in elderly patients with non st elevation acute coronary syndrome
    Gonzalez Sanchez, Maria Teresa
    Gallego Delgado, Maria
    Martin Herrero, Francisco
    Cano Mozo, Teresa
    Lopez Jimenez, Rosa Ana
    Clemente Lorenzo, Milagros
    Martin Garcia, Ana
    Martin Moreiras, Javier
    Pabon Osuna, Pedro
    Martin Luengo, Candido
    CIRCULATION, 2012, 125 (19) : E870 - E871
  • [44] Effect of an Invasive Strategy on Outcome in Patients ≥75 Years of Age With Non-ST-Elevation Acute Coronary Syndrome
    Galasso, Gennaro
    De Servi, Stefano
    Savonitto, Stefano
    Strisciuglio, Teresa
    Piccolo, Raffaele
    Morici, Nuccia
    Murena, Ernesto
    Cavallini, Claudio
    Petronio, Anna Sonia
    Piscione, Federico
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 115 (05): : 576 - 580
  • [45] FONDAPARINUX WITH UNFRACTIONATED HEPARIN DURING REVASCULARISATION IN ACUTE CORONARY SYNDROMES (FUTURA/OASIS 8): A RANDOMISED TRIAL EVALUATING THE SAFETY OF TWO REGIMENS OF ADJUNCTIVE INTRAVENOUS UNFRACTIONATED HEPARIN DURING PERCUTANEOUS CORONARY INTERVENTION IN HIGH-RISK PATIENTS WITH NON-ST SEGMENT ELEVATION ACUTE CORONARY SYNDROMES INITIALLY TREATED WITH SUBCUTANEOUS FONDAPARINUX
    Jolly, S. S.
    Steg, G.
    Mehta, S. R.
    Chrolavicius, S.
    Meeks, B.
    Bertrand, O.
    Tanguay, J.
    Yusuf, S.
    CANADIAN JOURNAL OF CARDIOLOGY, 2010, 26 : 147D - 147D
  • [46] Correlation of Risk Scores with Coronary Anatomy in Non-ST-elevation Acute Coronary Syndrome
    dos Santos, Elizabete Silva
    Aguiar Filho, Luciano de Figueiredo
    Fonseca, Daniela Menezes
    Londero, Hugo Jose
    Xavier, Rogerio Martins
    Pereira, Marcos Paulo
    Minuzzo, Luiz
    de Souza, Roberta
    Timerman, Ari
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2013, 100 (06) : 511 - 517
  • [47] Enoxaparin failed to show superiority to unfractionated heparin in patients with non ST-elevation acute coronary syndrome in a phase of A to Z trial
    Gratsiansky, NA
    KARDIOLOGIYA, 2003, 43 (06) : 70 - 71
  • [48] Cost-effectiveness of fondaparinux versus enoxaparin in non-ST-elevation acute coronary syndrome in Canada (OASIS-5)
    Jorge Alfonso Ross Terres
    G. Lozano-Ortega
    R. Kendall
    M. J. Sculpher
    BMC Cardiovascular Disorders, 15
  • [49] CARDIORENAL INTERRELATIONS IN PATIENTS WITH NON-ST-ELEVATION ACUTE CORONARY SYNDROME AND NON-INVASIVE STRATEGY
    Avdoshina, S.
    Villevalde, S.
    Kobalava, Z.
    JOURNAL OF HYPERTENSION, 2015, 33 : E136 - E136
  • [50] Hospital stay in patients with non-ST-elevation acute coronary syndromes
    Bellenger, NG
    Eichhöfer, J
    Crone, D
    Curzen, N
    LANCET, 2004, 363 (9418): : 1399 - 1400
12345